Latest Pressure BioSciences Inc. Stories
Company Also Closes $500,000 Convertible Debenture SOUTH EASTON, Mass., June 14, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that it has closed the third and final tranche of its Series J Private Placement of Convertible Preferred Stock and Warrants (the "Series J Private Placement"). Combined with two earlier tranche closings ($1,702,800 on February 6 and $156,900 on March 28, 2013), the Company has now closed a total of...
Pivotal PCT Platform Development Will Allow Processing of High Throughput Multiwell Plate Format and Integration with Laboratory Automation; Novel Design Expected to Have Significant Impact on Company's Growth SOUTH EASTON, Mass., June 4, 2013 /PRNewswire/ -- During their presentation at the Marcum SmallCap Conference on May 30, 2013 (http://wsw.com/webcast/marcum/pbio/), Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") announced they have achieved and passed...
SOUTH EASTON, Mass., May 28, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the 2(nd) Annual Marcum MicroCap Conference on Thursday, May 30(th), at 4:00 pm EDT. The Conference is being held at the Grand Hyatt Hotel in New York City. Mr. Schumacher's presentation will be webcast and may be viewed live at the following link...
SOUTH EASTON, Mass., May 23, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2013 financial results and to provide a business update. The teleconference information is provided below: Date: Thursday, May 23, 2013Time: 11:00 a.m. Eastern Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 (Canada); (302) 607-2001 (Int'l)Passcode: VS22823 For...
Pressure BioSciences' PCT Platform Enhances Study Results SOUTH EASTON, Mass., May 16, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced the publication in the journal Analytical Chemistry of a study by a team of scientists led by Dr. Bruce Kristal, Associate Professor of Surgery at Harvard Medical School and the Department of Neurosurgery at Brigham and Women's Hospital, entitled: Method Development for Fecal Lipidomics...
Company Plans to Expand Collaborative Efforts with Key Forensics Groups in an Effort to Accelerate Timetable to Launch Their PCT-based Rape Kit Processing System SOUTH EASTON, Mass., April 4, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that scientists from Florida International University ("FIU") reported further advancements in their goal to develop an improved method for rape kit testing based on PBI's patented pressure...
SOUTH EASTON, Mass., March 11, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at SeeThruEquity's Spring Investor Microcap Forum on Tuesday, March 12(th) at 3:20 pm EDT. The Investor Forum is being held at the Penn Club, 30 West 44(th) Street, New York, NY. Registration for the Investor Forum is available at www.seethruequity.com. Mr....
SOUTH EASTON, Mass., Feb. 12, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Dr. Mickey Urdea has been appointed to its Board of Directors, effective Friday, February 8, 2013. Dr. Urdea will fill the vacancy created by the resignation of Mr. Wayne Fritzsche, a longtime Board member who resigned on Thursday, February 7, 2013 to pursue a full-time, management position with PBI. Dr. Urdea will be a Class III Board member -...
SOUTH EASTON, Mass., Dec. 5, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Conrad F. Mir has joined the Company as its chief financial officer ("CFO"), effective immediately. Mr. Mir has over twenty years experience in investment banking, financial structuring, and corporate reengineering. He has served in various executive management roles and on the Board of Directors of several companies in the biotechnology...
SOUTH EASTON, Mass., Dec. 3, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview at the 5(th) Annual LD MICRO Growth Conference on Thursday, December 6(th) at 2:30 PM PST. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, California. LD MICRO showcases some of the fastest growing and profitable names on the OTC,...
